Interview with Eitan Konstantino, President and CEO, TriReme Medical
What prompted you to found TriReme six years ago? I set up companies, so TriReme was not the first. The idea behind TriReme was to provide solutions for complex cases,…
Address: 3A International Business Park
#09-10/12 ICON @ IBP Tower B
Singapore 609935
Tel:
Web: http://www.trirememedical.com/
Based in Pleasanton, California and Singapore, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets.
Design, manufacture, and distribution of advanced therapeutic solutions for the treatment of complex vascular disease
What prompted you to found TriReme six years ago? I set up companies, so TriReme was not the first. The idea behind TriReme was to provide solutions for complex cases,…
CEO of the Asia Pacific Medical Technology Association (APACMed), Fredrik Nyberg explains the rationale behind the creation of the first regional medical technology association; the industry challenges ahead, and the…
Toshifumi Tada, Managing Director of MT Pharma, shares the significance of Singapore to their presence in the region, the strategic direction of the company to “open up the future,” as…
BD’s Executive VP & President of Greater Asia, James Lim on the concept of “Shared Value” and how this idea has served to advance healthcare systems across the region, while…
Mundipharma’s president of Asia Pacific, Latin America, and the Middle East and Africa, Raman Singh defines the underlying drivers behind the company’s explosive growth, while sharing his insights on what…
The French ambassador to Singapore showcases the importance of the Asian country to France as a regional hub, the footprint of the French business community in the Singaporean economy, and…
Dublin-based Allergan has undergone many changes recently, with the acquisition by Actavis, the failed merger with Pfizer, and the divestiture of the generics business to Teva. The company’s SVP and…
Established in November 2014, Amgen’s Next-Generation Biomanufacturing facility in Singapore heralds a new juncture of efficient and innovative commercial-scale production of medicines. VP of Singapore Site Operations, Arleen Paulino, pinpoints…
With Amgen having recently reacquired the sales rights to three of its drugs, the company’s GM in Singapore and Malaysia, Raphael Ho, explains the rationale behind Amgen’s recent entry in…
LEO Pharma’s senior area director for South Asia, Ricky Teo, explains the company’s strategy for obtaining growth within such a heterogeneous region and showcases how the organization’s commitment to healthier…
The executive director of the Singaporean-German Chamber of Industry and Commerce explains the evolution of the business relationship between Singapore and Germany, cultural similarities and challenges, and showcases the chamber…
Renaud Jonquieres, Vice President Asia-Pacific of bioMérieux Industry, enthusiastically conveys the company’s scope and significance in the Asia-Pacific region, the competitive landscape, as well as the key strategic objective to…
Attract, Transform, and Create. The Singapore Economic Development Board’s (EDB) director of biomedical sciences, Weng Si Ho highlights these three actions as the primary strategic focuses of the organization from…
See our Cookie Privacy Policy Here